3rd Annual Conference 2017
3rd – 5th October 2017
Crowne Plaza Hotel – Blanchardstown, Dublin, Ireland

The Use of ASAP from Early to Late Pharmaceutical Development

  • 0

The Use of ASAP from Early to Late Pharmaceutical Development

The Use of ASAP from Early to Late Pharmaceutical Development

Eduard Luss, Ph.D.
Sr. Scientist, Vertex Pharmaceuticals
Boston, MA, USA

The presentation covers a brief overview of ASAP, experimental design and its advantages in pharmaceutical development when compared to other typical approaches.  Also, ASAP implementation in early development projects is demonstrated; including regulatory implications during filing of the data.  Potential use in late pharmaceutical development is also discussed.